Form 4: Natera Co-Founder Jonathan Sheena Sells Shares to Cover Tax Obligations

Jonathan Sheena, co-founder of Natera, Inc., sold 439 shares of common stock on April 28, 2025, to satisfy tax withholding obligations related to vesting RSUs.

Summary

• On April 28, 2025, Jonathan Sheena, a co-founder of Natera, Inc., sold 439 shares of Natera's common stock.
• The shares were sold at a price of $152.1824 per share.
• This transaction was executed to cover tax withholding and remittance obligations associated with the vesting of Restricted Stock Units (RSUs).
• The sale was conducted under a pre-arranged written instruction intended to comply with Rule 10b5-1(c) of the Exchange Act.
• Following the transaction, Sheena directly owns 254,914 shares of Natera's common stock.
• Sheena also indirectly owns 40,282 shares through the Caraluna 1 Trust and 40,282 shares through the Caraluna 2 Trust, but disclaims beneficial ownership of these shares.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to an insider stock sale for tax purposes. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares by company insiders are a common occurrence, often related to compensation or personal financial planning. The use of Rule 10b5-1(c) trading plans is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are widely used by executives at publicly traded companies, including those in the biotechnology and diagnostics sectors like Illumina, Exact Sciences, and Guardant Health, to manage their stock sales in compliance with insider trading regulations.
• The volume of shares sold (439) is relatively small compared to the total shares owned directly (254,914) and indirectly (80,564), suggesting this is a routine transaction for tax purposes rather than a significant divestment.
• The price per share of $152.1824 reflects the market valuation of Natera at the time of the transaction, which can be compared to the stock performance of similar companies in the genetic testing industry.

Stakeholder Impact

• The sale of shares by a co-founder could have a minor psychological impact on shareholders, but the small size of the transaction and the explanation provided (tax obligations) should mitigate any significant concerns.
• Employees may be indirectly affected as insider transactions are often monitored as a sign of company health, but this particular transaction is unlikely to cause alarm due to its routine nature.

Key Dates

Keywords

Natera, NTRA, Jonathan Sheena, Form 4, Stock Sale, RSUs, Rule 10b5-1(c), Beneficial Ownership, Caraluna Trust, Tax Withholding